← Back to Search

Outreach Strategies for Cancer Trial Enrollment (ACT WONDER²S Trial)

N/A

Recruiting

Led By Susan Vadaparampil, PhD

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve the enrollment of Black and Hispanic patients in cancer treatment trials at a specific cancer center.

Who is the study for?

This trial is for Black and Hispanic individuals interested in participating in cancer clinical trials at Moffitt Cancer Center. It aims to increase their enrollment in NCI-sponsored therapeutic clinic trials.

What is being tested?

The study tests a multi-level intervention including patient information, digital portals, educational events, an eligibility calculator, newsletters, recruitment dashboard, implicit bias training and support lines to improve trial enrollment rates.

What are the potential side effects?

Since this trial focuses on outreach and education rather than medical treatments or drugs, there are no direct side effects associated with the interventions being studied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Enrollment of Black and Hispanic Patients to NCI-sponsored cancer treatment clinical trials

Secondary study objectives

Cancer Center CRC

Cancer Center Physician

Community physicians in the intervention CAPZ

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups

Experimental Treatment

Active Control

Group I: Catchment Area Priority Zone (CAPZ) Intervention - Community Residents and Moffitt PatientsExperimental Treatment3 Interventions

Study interventions will be deployed in geographically defined intervention priority zones including Clinical Trial Education sessions and the ACT WONDER²S Phone-line/Email. Community residents in these zones may be exposed to these interventions. Residents who are also new patients to Moffitt may be exposed to the CHOICES DA website once they are registered at Moffitt.

Group II: Catchment Area Priority Zone (CAPZ) Intervention - Community PhysiciansExperimental Treatment3 Interventions

Study interventions will be deployed in geographically defined intervention priority zones including Continuing Medical Education events, the Trial Connect Portal, and Clinical Trial Newsletters. Community physicians in these zones may be exposed to these interventions.

Group III: Cancer Center PhysiciansExperimental Treatment5 Interventions

Physicians at Moffitt will have access to the implicit bias educational module and to digital tools to monitor and enhance minority recruitment, including the Trial Connect Portal, Recruitment Dashboard, Portfolio Profiler, and the Eligibility Criteria Calculator.

Group IV: Cancer Center Clinical Research Coordinators (CRCs)Experimental Treatment3 Interventions

CRCs that work on therapeutic clinical trials at Moffitt will have access to the implicit bias educational module and digital tools to monitor and enhance minority recruitment, including the Trial Connect Portal and Recruitment Dashboard.

Group V: Catchment Area Priority Zone (CAPZ) Control - Community Residents and Moffitt PatientsActive Control1 Intervention

Study interventions will not be deployed in the control priority zones. Community residents in these zones are unlikely to be exposed to any of the study interventions.

Group VI: Catchment Area Priority Zone (CAPZ) Control- Community PhysiciansActive Control1 Intervention

Study interventions will not be deployed in the control priority zones. Community physicians in these zones are unlikely to be exposed to any of the study interventions.

Do I qualify?Apply below to find out